The test operates on the principle that cancers shed DNA into the bloodstream
The data also noted that 23 per cent of Canadians diagnosed with cancer
Pollution appears to be the primary culprit for the phenomenon
MASH is a more severe form of metabolic dysfunction-associated steatotic liver disease formerly known as non-alcoholic fatty liver disease
This study targets a significant patient population with hypertension, and holds promise for substantial market impact if successful
The year’s economic landscape as 2024 comes to a close demonstrates the resilience and adaptability of key sectors
These developments are a validation of Personalis' business strategy and its potential in the genomics and cancer treatment space
Chinese-based Hansoh Pharma is conducting the trial to evaluate GSK'227 in patients with locally advanced or metastatic solid tumours
New research has highlighted that they can increase your risk of lung cancer
The Galleri test works by analyzing DNA fragments shed by cancer cells into the bloodstream
The deal represents a 67 per cent premium to Cross Country's closing price on December 3, 2024
The nation is facing a lung cancer epidemic from the heavy pollution
Even if you have a healthy lifestyle and don't smoke you should still get checked out, she says
Poseida's proprietary non-viral gene engineering technology has delivered promising early clinical results
The key developments are led by advances in robotic-assisted surgical systems and imaging technologies
Only 16.0 per cent of eligible individuals underwent lung cancer screening in 2022
The Honest Company has US$53 million in cash and no debt
Aaron Roebuck brings three decades of experience in respiratory and cardiopulmonary medicine, and commercialization of medical devices
The "Great World Race" through all 7 continents is sponsored by the LUNGevity Foundation non-profit
Investor confidence rose with these results, particularly due to Stern’s upcoming leadership starting in January 2025
The company focuses on oral delivery of biologics, and may be benefiting from investor speculation
The American Cancer Society says one in four men and one in five women will develop cancer at some point in their lives
Smoking remains the leading cause of preventable death worldwide, serving as the primary risk factor for lung cancer
A Utah man recently lost his wife due to the toxic gas and is encouraging people to test their homes
Combatting air pollution and quitting smoking are also key themes
Several analysts upgraded their price targets for Relay Therapeutics based on the release
The team published details of a radiomics-based reinforcement learning model to predict malignancy risk for nodules
Early detection is crucial in improving survival rates and the chances of successful treatment for lung cancer
OceanMD eliminates inefficiencies of paper-based processes by direct integration with electronic medical records systems
Early research shows ashwagandha can help reduce stress and anxiety, improve energy levels and cognitive function
This access is to facilitate earlier diagnosis and identification of patients with potential risk of certain conditions
Investment in AstraZeneca's new Rockville Facility to propel cancer treatment research and development
Investor confidence wavers as Peloton struggles to overcome operational challenges
Bridging health equity through technological access: WHO's HTAP launch
Exploring Novo Nordisk's Wegovy with broader applications, rising demands, and regulatory impacts
Results of the study were published in the journal Neuropsychopharmacology
Partnership signals a milestone agreement for innovative treatment solutions
The funding is to help develop the product's machine learning and data collection components
The potency of coca for beverage flavoring has been recognized since the 19th century
Dr. GenAI can gather information about an individual to understand their unique medical profile








































